FDA Drug Safety Website Under Development As One Response To Concerns
Executive Summary
FDA is understood to be developing a drug safety website as part of an initiative to address concerns about post-marketing surveillance
You may also be interested in...
FDA Unveils Rx Safety Board, Website; Postmarket Surveillance Overhaul Next
HHS is planning a major overhaul of FDA's postmarketing surveillance system as the centerpiece of its next announcement about upgrades to the drug safety regulatory system
FDA Unveils Rx Safety Board, Website; Postmarket Surveillance Overhaul Next
HHS is planning a major overhaul of FDA's postmarketing surveillance system as the centerpiece of its next announcement about upgrades to the drug safety regulatory system
Drug Safety Concerns Will Increase FDA-Industry Interactions, Schering Says
Schering-Plough predicts that increased attention on drug safety issues will drive greater interactions with FDA